Raimond Heukers

2.0k citations

47 papers · 1.5k indexed · h-index 23

Radiology, Nuclear Medicine and Imaging top 2%
- Monoclonal and Polyclonal Antibodies Research 27
Immunology top 10%
- Immunotherapy and Immune Responses 6
Molecular Biology top 10%
- Glycosylation and Glycoproteins Research 13
- Receptor Mechanisms and Signaling 8
Oncology top 10%
- Chemokine receptors and signaling 8
- HER2/EGFR in Cancer Research 4
Biomaterials top 10%
Pulmonary and Respiratory Medicine
- Photodynamic Therapy Research Studies 6
Biomedical Engineering
- Nanoplatforms for cancer theranostics 5

Co-authors: Paul M.P. van Bergen en Henegouwen Sabrina Oliveira Martine J. Smit Robbert J. Kok Timo W.M. De Groof Vladimir Bobkov Wim E. Hennink Raymond M. Schiffelers
Cited by: Radiology, Nuclear Medicine and Imaging Immunology Molecular Biology
Journals: Science (1 paper)Proceedings of the National Academy of Sciences (1 paper)Journal of Biological Chemistry (2 papers)
Partner nations: Netherlands Belgium United Kingdom

In The Last Decade

Raimond Heukers

45 papers receiving 1.5k citations

Peers

Countries citing papers authored by Raimond Heukers

Since Specialization

Citations

This map shows the geographic impact of Raimond Heukers's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Raimond Heukers with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Raimond Heukers more than expected).

Fields of papers citing papers by Raimond Heukers

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Raimond Heukers. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Raimond Heukers. The network helps show where Raimond Heukers may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Raimond Heukers, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Raimond Heukers Line = papers co-authored together Raimond Heukers links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Constitutive activity of an atypical chemokine receptor revealed by inverse agonistic nanobodies Nature Communications ·Claudia V. Perez Almeria,Omolade Otun,Roman R. Schlimgen,Thomas D Lamme,Lotte Di Niro,Caitrin Crudden,Jan Paul Bebelman,Noureldine Youssef,Lejla Musli,Shawn Jenjak,Vladimir Bobkov,Julia Drube,Carsten Hoffmann,Brian F. Volkman,Sébastien Granier,Chérine Bechara,Marco Siderius,Raimond Heukers,Christopher T. Schafer,Martine J. Smit	2025	0
2	Indium-111-Labeled Single-Domain Antibody for In Vivo CXCR4 Imaging Using Single-Photon Emission Computed Tomography Bioconjugate Chemistry ·M. SPAHN,Stephanie Mareike Anbuhl,Kaat Luyten,Tom Van Loy,Matti F. Pronker,Christopher Cawthorne,Christophe M. Deroose,Dominique Schols,Raimond Heukers,Guy Bormans,Frederik Cleeren	2025	0
3	Structural basis for selectivity and antagonism in extracellular GPCR-nanobodies Nature Communications ·Roman R. Schlimgen,Francis C. Peterson,Raimond Heukers,Martine J. Smit,John D. McCorvy,Brian F. Volkman	2024	10
4	Inhibition of HIV-1 replication by nanobodies targeting tetraspanin CD9 iScience ·Jeffrey C. Umotoy,Pascal Z. Kroon,S. F. Paul Man,Karel A. van Dort,Tuğba Atabey,Angela I. Schriek,Gillian Dekkers,Elena Herrera-Carrillo,Teunis B. H. Geijtenbeek,Raimond Heukers,Neeltje A. Kootstra,Marit J. van Gils,Steven W. de Taeye	2024	2
5	Nanobody-liposomes as novel cancer vaccine platform to efficiently stimulate T cell immunity International Journal of Pharmaceutics ·Rianne G. Bouma,Maarten K. Nijen Twilhaar,Hendrik J. Brink,Alsya J. Affandi,Bárbara Mesquita,Katarzyna Olesek,J.M.A. van Dommelen,Raimond Heukers,Alexandra Haas,Hakan Kalay,Martino Ambrosini,Josbert M. Metselaar,Anita Van Rooijen,G. Storm,Sérgio C. Oliveira,Yvette van Kooyk,Joke M. M. den Haan	2024	7
6	Conformational selection guides β-arrestin recruitment at a biased G protein–coupled receptor Science ·Andrew B. Kleist,Shawn Jenjak,Andrija Sente,Lauren J. Laskowski,Martyna Szpakowska,Maggie M. Calkins,Emilie I. Anderson,Lisa McNally,Raimond Heukers,Vladimir Bobkov,Francis C. Peterson,Monica A. Thomas,Andy Chevigné,Martine J. Smit,John D. McCorvy,M. Madan Babu,Brian F. Volkman	2022	25
7	Viral G Protein–Coupled Receptors: Attractive Targets for Herpesvirus-Associated Diseases Pharmacological Reviews ·Timo W.M. De Groof,Elizabeth Elder,Marco Siderius,Raimond Heukers,John Sinclair,Martine J. Smit	2021	16
8	Anti-CfaE nanobodies provide broad cross-protection against major pathogenic enterotoxigenic Escherichia coli strains, with implications for vaccine design Scientific Reports ·Alla Amcheslavsky,Aaron Wallace,Monir Ejemel,Qi Li,Conor McMahon,Matteo Stoppato,Serena Giuntini,Zachary A. Schiller,Jessica R. Pondish,Jacqueline R. Toomey,Ryan M. Schneider,Jordan Meisinger,Raimond Heukers,Andrew C. Kruse,Eileen M. Barry,Brian G. Pierce,Mark S. Klempner,Lisa A. Cavacini,Yang Wang	2021	28
9	Selective targeting of ligand-dependent and -independent signaling by GPCR conformation-specific anti-US28 intrabodies Nature Communications ·Timo W.M. De Groof,Nick D. Bergkamp,Raimond Heukers,Truc Giap,Maarten P. Bebelman,Richard Goeij-de Haas,Sander R. Piersma,Connie R. Jiménez,K. Christopher García,Hidde L. Ploegh,Marco Siderius,Martine J. Smit	2021	23
10	Monitoring Allosteric Interactions with CXCR4 Using NanoBiT Conjugated Nanobodies Cell chemical biology ·Mark Soave,Raimond Heukers,Barrie Kellam,Jeanette Woolard,Martine J. Smit,Stephen J. Briddon,Stephen J. Hill	2020	22
11	Nanobodies: New avenues for imaging, stabilizing and modulating GPCRs Molecular and Cellular Endocrinology ·Timo W.M. De Groof,Vladimir Bobkov,Raimond Heukers,Martine J. Smit	2019	44
12	The human cytomegalovirus-encoded G protein–coupled receptor UL33 exhibits oncomodulatory properties Journal of Biological Chemistry ·Jeffrey R. van Senten,Maarten P. Bebelman,Tian Shu Fan,Raimond Heukers,Nick D. Bergkamp,Puck van Gasselt,Ellen Langemeijer,Erik Slinger,Tonny Lagerweij,Afsar Rahbar,Marijke Stigter-van Walsum,David Maussang,Rob Leurs,René J.P. Musters,Guus A.M.S. van Dongen,Cecilia Söderberg‐Nauclér,Thomas Würdinger,Marco Siderius,Martine J. Smit	2019	23
13	Nanobodies detecting and modulating GPCRs outside in and inside out Current Opinion in Cell Biology ·Raimond Heukers,Timo W.M. De Groof,Martine J. Smit	2019	43
14	CXCR4-targeting nanobodies differentially inhibit CXCR4 function and HIV entry Biochemical Pharmacology ·Anneleen Van Hout,A. Klarenbeek,Vladimir Bobkov,Jordi Doijen,Marta Arimont,Chunxia Zhao,Raimond Heukers,Rebecca Rimkunas,Chris de Graaf,Theo Verrips,Bas van der Woning,Hans de Haard,Joseph Rucker,Kurt Vermeire,Tracy M. Handel,Tom Van Loy,Martine J. Smit,Dominique Schols	2018	43
15	Nanobody-Fc constructs targeting chemokine receptor CXCR4 potently inhibit signaling and CXCR4-mediated HIV-entry and induce antibody effector functions Biochemical Pharmacology ·Vladimir Bobkov,Aurélien Zarca,Anneleen Van Hout,Marta Arimont,Jordi Doijen,Magdalena Bialkowska,Elisa C. Toffoli,A. Klarenbeek,Bas van der Woning,Hans van Vliet,Tom Van Loy,Hans de Haard,Dominique Schols,Raimond Heukers,Martine J. Smit	2018	53
16	CXCR4-Specific Nanobodies as Potential Therapeutics for WHIM syndrome Journal of Pharmacology and Experimental Therapeutics ·Raymond H. de Wit,Raimond Heukers,Hendrik J. Brink,Angela Arsova,David Maussang,Pasquale Cutolo,Beatrijs Strubbe,Henry F. Vischer,Françoise Bachelerie,Martine J. Smit	2017	25
17	Nanobody–photosensitizer conjugates for targeted photodynamic therapy Nanomedicine Nanotechnology Biology and Medicine ·Raimond Heukers,Paul M.P. van Bergen en Henegouwen,Sabrina Oliveira	2014	83
18	Targeting tumors with nanobodies for cancer imaging and therapy Journal of Controlled Release ·Sabrina Oliveira,Raimond Heukers,Jirawas Sornkom,Robbert J. Kok,Paul M.P. van Bergen en Henegouwen	2013	177
19	Nanobody-albumin nanoparticles (NANAPs) for the delivery of a multikinase inhibitor 17864 to EGFR overexpressing tumor cells Journal of Controlled Release ·Işıl Altıntaş,Raimond Heukers,Roy van der Meel,M. Lacombe,Maryam Amidi,Paul M.P. van Bergen en Henegouwen,Wim E. Hennink,Raymond M. Schiffelers,Robbert J. Kok	2012	97
20	Indole-3-carbinol-induced modulation of NF-κB signalling is breast cancer cell-specific and does not correlate with cell death Breast Cancer Research and Treatment ·Elena P. Moiseeva,Raimond Heukers	2007	7

About Raimond Heukers

Raimond Heukers is a scholar working on Radiology, Nuclear Medicine and Imaging, Immunology and Toxicology, having authored 47 papers that have together received 1.5k indexed citations. Recurring topics across this work include Monoclonal and Polyclonal Antibodies Research (27 papers), Glycosylation and Glycoproteins Research (13 papers), Chemokine receptors and signaling (8 papers), Receptor Mechanisms and Signaling (8 papers), Photodynamic Therapy Research Studies (6 papers), Immunotherapy and Immune Responses (6 papers), Nanoplatforms for cancer theranostics (5 papers) and HER2/EGFR in Cancer Research (4 papers). The work is most often cited by research in Radiology, Nuclear Medicine and Imaging (709 citations), Immunology (309 citations) and Molecular Biology (860 citations). Raimond Heukers has collaborated with scholars based in Netherlands, Belgium and United Kingdom. Frequent co-authors include Paul M.P. van Bergen en Henegouwen, Sabrina Oliveira, Martine J. Smit, Robbert J. Kok, Timo W.M. De Groof, Vladimir Bobkov, Wim E. Hennink, Raymond M. Schiffelers, Işıl Altıntaş and Elena P. Moiseeva. Their work appears in journals such as Science, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact